Published in J Signal Transduct on June 18, 2012
The hallmarks of cancer. Cell (2000) 113.05
Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature (2008) 75.40
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
An integrated genomic analysis of human glioblastoma multiforme. Science (2008) 51.36
A microRNA polycistron as a potential human oncogene. Nature (2005) 40.21
IDH1 and IDH2 mutations in gliomas. N Engl J Med (2009) 32.41
The epigenomics of cancer. Cell (2007) 30.91
The fundamental role of epigenetic events in cancer. Nat Rev Genet (2002) 30.05
MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med (2005) 29.65
Genetic instabilities in human cancers. Nature (1998) 22.76
Long non-coding RNAs: insights into functions. Nat Rev Genet (2009) 19.61
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res (2005) 18.58
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Microsatellite instability in cancer of the proximal colon. Science (1993) 14.51
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (1993) 12.74
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol (2006) 11.56
Non-coding RNAs in human disease. Nat Rev Genet (2011) 11.40
The expanding role of mitochondria in apoptosis. Genes Dev (2001) 9.91
Epigenetic stem cell signature in cancer. Nat Genet (2006) 9.62
Genetic pathways to primary and secondary glioblastoma. Am J Pathol (2007) 9.27
A gene hypermethylation profile of human cancer. Cancer Res (2001) 8.93
Genetic pathways to glioblastoma: a population-based study. Cancer Res (2004) 8.87
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A (1994) 8.47
Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun (2005) 7.50
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res (1995) 7.42
Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science (1997) 7.31
Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell (2007) 7.05
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol (2005) 6.16
An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science (1997) 6.10
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene (2002) 5.96
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med (2008) 5.91
Cancer-susceptibility genes. Gatekeepers and caretakers. Nature (1997) 5.87
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol (2008) 5.21
Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med (2000) 5.04
Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res (1993) 4.93
Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res (2008) 4.64
Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol (1996) 4.18
MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res (2008) 3.70
Death receptor-induced cell killing. Cell Signal (2004) 3.67
Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol (2007) 3.53
Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol (1995) 3.53
Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet (2007) 3.12
Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet (1994) 2.45
PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet (1997) 2.44
DNA damage-induced apoptosis. Oncogene (2004) 2.32
A microarray-based DNA methylation study of glioblastoma multiforme. Epigenetics (2009) 2.21
Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res (2006) 2.18
Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Cancer Res (1999) 2.17
Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification. Cancer Res (1999) 1.83
Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. Cancer Res (1998) 1.75
Deregulation of the p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res (2000) 1.74
Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene. Carcinogenesis (2001) 1.71
Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Proc Natl Acad Sci U S A (2006) 1.70
Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. J Neurosurg (1994) 1.67
Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. Am J Pathol (2004) 1.58
Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem (1997) 1.56
Promoter hypermethylation of the RB1 gene in glioblastomas. Lab Invest (2001) 1.54
WRN mutations in Werner syndrome patients: genomic rearrangements, unusual intronic mutations and ethnic-specific alterations. Hum Genet (2010) 1.50
Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer. Oncogene (2004) 1.49
Molecular pathways in the formation of gliomas. Glia (1995) 1.43
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. Ann Oncol (2001) 1.41
How epigenetics can explain human metastasis: a new role for microRNAs. Cell Cycle (2009) 1.41
Molecular diagnostics of gliomas: state of the art. Acta Neuropathol (2010) 1.40
Distinct methylation profiles of glioma subtypes. Int J Cancer (2003) 1.38
EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma. Cancer Res (2005) 1.37
Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. Int J Cancer (2008) 1.33
Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma. Eur J Cancer (2002) 1.32
Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg (1992) 1.28
p14ARF deletion and methylation in genetic pathways to glioblastomas. Brain Pathol (2001) 1.27
CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Carcinogenesis (2007) 1.25
Epigenetic silencing of the protocadherin family member PCDH-gamma-A11 in astrocytomas. Neoplasia (2005) 1.24
RecQ family helicases: roles as tumor suppressor proteins. Oncogene (2002) 1.18
The p53 gene and its role in human brain tumors. Glia (1995) 1.11
Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme. J Neurooncol (2006) 1.08
A molecular genetic model of astrocytoma histopathology. Brain Pathol (1997) 1.07
Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression. Brain Pathol (2007) 1.00
Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet (2003) 0.99
Classification of glioblastoma multiforme in adults by molecular genetics. Cancer J (2003) 0.99
Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes. J Neuropathol Exp Neurol (2001) 0.98
Microsatellite instability and mutations of p53 and TGF-beta RII genes in gastric cancer. Hum Genet (1996) 0.95
Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Oncogene (2007) 0.95
Epigenetic inactivation of RASSF1A candidate tumor suppressor gene at 3p21.3 in brain tumors. Oncogene (2003) 0.94
Long-term survival of glioblastoma multiforme: importance of histopathological reevaluation. J Neurol (2000) 0.91
Low-level microsatellite instability phenotype in sporadic glioblastoma multiforme. J Cancer Res Clin Oncol (2004) 0.89
Microsatellite instability in squamous cell carcinoma of the head and neck. Br J Cancer (1995) 0.89
Cellular mechanisms targeted during astrocytoma progression. Cancer Lett (2002) 0.84
Mining methylation for early detection of common cancers. PLoS Med (2006) 0.84
Downregulation of WIF-1 by hypermethylation in astrocytomas. Acta Biochim Biophys Sin (Shanghai) (2010) 0.83
Molecular epidemiology of glioblastoma. Cancer J (2003) 0.80
Microsatellite instability in latent prostate cancers. Int J Cancer (1996) 0.76